AMTG Stock | News | Financials | Filings | Forum | Research |

New Post Public Reply Private Reply Replies (0) Message Board
Langan
Apollo Residential Mortgage Inc.  AMTG Company Overview

Apollo Residential Mortgage, Inc. operates as a holding company and conducts its business primarily through ARM Operating, LLC and its other operating subsidiaries. The company is primarily engaged in the business of investing, on a leveraged basis, in residential Agency and non-Agency RMBS in the United States. Its principal objective is to provide attractive risk-adjusted returns from its assets to stockholders over the long term, primarily through dividend distributions and secondarily through capital appreciation. Apollo invests in residential mortgage assets throughout the United States. Its investment portfolio is comprised of: Agency RMBS, including pass-through securities (whose underlying collateral includes only fixed-rate mortgages), Agency IOs and Agency Inverse IOs; and non-Agency RMBS. The company is headquartered in New York, NY.

AMTG Last Price: 15.72

Last Updated: October 26, 2013 11:23 AM

AMTG Stock Message Board and Forum http://investorshangout.com/search?q=AMTG&...mp;yt0=Go!

Apollo Residential Mortgage Inc. AMTG Officers and Executives
Name Age Officer Since Title
Mr. Frederick N. Khedouri 62 - Chairman
Mr. Michael A. Commaroto 56 - President, Chief Executive Officer & Director
Mr. Stuart A. Rothstein 47 - Chief Financial Officer, Secretary & Treasurer
Ms. Keith Rosenbloom - - Agency Portfolio Manager
Mr. Justin A. Stevens 33 - Director

Apollo Residential Mortgage, Inc.
9 West 57th Street
43rd floor
New York, New York 10019
Phone
1 2125153200
Industry
Mortgage REITs
Sector
Financials
Fiscal Year-end
12/2013
View SEC Filings Below
Revenue
$121.72M
Net Income
$172.15M
2012 Sales Growth
947.5%
Employees
-
Annual Report Below for AMTG

Apollo Residential Mortgage Inc. AMTG Recent Headlines

Valuation
P/E Current
1.88
P/E Ratio (with extraordinary items)
10.78
P/E Ratio (without extraordinary items)
2.42
Price to Sales Ratio
3.31
Price to Book Ratio
0.68
Price to Cash Flow Ratio
6.82
Enterprise Value to EBITDA
22.55
Enterprise Value to Sales
31.71
Total Debt to Enterprise Value
0.96
Efficiency
Receivables Turnover
15.96
Total Asset Turnover
0.04

Profitability
Gross Margin
100.00
Operating Margin
141.93
Pretax Margin
141.93
Net Margin
141.43
Return on Assets
5.83
Return on Equity
37.37
Return on Total Capital
6.09
Return on Invested Capital
37.37
Capital Structure
Total Debt to Total Equity
509.89
Total Debt to Total Capital
83.60
Total Debt to Total Assets
81.43
Long-Term Debt to Equity
0.00
Long-Term Debt to Total Capital
0.00

Apollo Residential Mortgage Inc. AMTG Financials

Apollo Residential Mortgage Inc. AMTG Filings

Apollo Residential Mortgage Inc. AMTG Insider Actions


AMTG Apollo Residential Mortgage Inc. Research Links

Stock Message Board http://investorshangout.com/search?q=AMTG&...mp;yt0=Go!
Stock Quote http://www.otcmarkets.com/stock/AMTG/quote
Stock Chart http://www.otcmarkets.com/stock/AMTG/chart
Company Info http://www.otcmarkets.com/stock/AMTG/company-info
Recent News http://www.otcmarkets.com/stock/AMTG/news
Financials http://www.otcmarkets.com/stock/AMTG/financials
Filings and Disclosure http://www.otcmarkets.com/stock/AMTG/filings
Short Sales http://www.otcmarkets.com/stock/AMTG/short-sales
Insider Disclosure http://www.otcmarkets.com/stock/AMTG/insider-transactions
Research Reports http://www.otcmarkets.com/stock/AMTG/research
Summary http://finance.yahoo.com/q?s=AMTG
Historical Prices http://finance.yahoo.com/q/hp?s=AMTG+Historical+Prices
Interactive Chart http://finance.yahoo.com/echarts?s=AMTG
Basic Chart http://finance.yahoo.com/q/bc?s=AMTG+Basic+Chart
Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=AMTG+Basic+Tech.+Analysis
Headlines http://finance.yahoo.com/q/h?s=AMTG+Headlines
Press Releases http://finance.yahoo.com/q/p?s=AMTG+Press+Releases
Company Profile http://finance.yahoo.com/q/pr?s=AMTG+Profile
Key Statistics http://finance.yahoo.com/q/ks?s=AMTG+Key+Statistics
Industry http://finance.yahoo.com/q/in?s=AMTG+Industry
Major Holders http://finance.yahoo.com/q/mh?s=AMTG+Major+Holders
Insider Transactions http://finance.yahoo.com/q/it?s=AMTG+Insider+Transactions
Insider Roster http://finance.yahoo.com/q/ir?s=AMTG+Insider+Roster
Income Statement http://finance.yahoo.com/q/is?s=AMTG
Balance Sheet http://finance.yahoo.com/q/bs?s=AMTG
Cash Flow http://finance.yahoo.com/q/cf?s=AMTG+Cash+Flow&annual
Nasdaq http://www.nasdaq.com/symbol/AMTG
Market Watch http://www.marketwatch.com/investing/stock/AMTG
Bloomberg http://www.bloomberg.com/quote/AMTG:US
Morningstar http://quotes.morningstar.com/stock/s?t=AMTG
Bussinessweek http://investing.businessweek.com/research/st...icker=AMTG
Barchart http://www.barchart.com/quotes/stocks/AMTG
OTC Short Report http://otcshortreport.com/index.php?index=AMTG
Investopedia http://www.investopedia.com/markets/stocks/AMTG/?wa=0

List of all stock message boards and tickers for NYSE New York Stock Exchange http://investorshangout.com/board?categoryid=NYSE
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Alaska's Insurance Maze: Coverage Over Cheap Policies

Updated Category News Views 92

Beyond Premiums: Assessing Real Coverage Needs The Alaskan wilderness isn't just home to stunning views; it's also a land where insurance needs to go beyond the average cookie-cutter policy. You'd think the cheapest option would suffice, but that's where residents might trip into financial quicksand. Devery Prince, a seasoned insurance principal, sheds light on why...

Continue Reading
Apalutamide Boosts Outlook for Prostate Cancer Treatment

Updated Category News Views 69

Fresh Findings on High-Risk Prostate Cancer Treatments In an industry that often feels like a game of chess, Johnson & Johnson's recent news unveils another one of their strategic moves with the announcement of breakthrough results from their Phase 3 PROTEUS substudy. Turns out, ERLEADA®, their apalutamide treatment, isn't just another pawn; it's a potential...

Continue Reading
Darden Faces Class Action Over Reimbursement Failures

Updated Category News Views 147

Class Action Puts Darden Restaurants in Legal Hot Seat Darden Restaurants, Inc. is staring down the barrel of a lawsuit that's as fiery as a grill on a Saturday night rush. The legal cavalry from Blumenthal Nordrehaug Bhowmik De Blouw LLP has stormed in with a class action complaint, aiming dead center at Darden for allegedly breaching the California Labor Code. In plain...

Continue Reading
ASTS Faces Crucial Deadline Amidst Legal Turmoil

Updated Category News Views 143

Ah, the ticking clock in the world of stock investments, where a nifty little thing called a class action lawsuit can flip your investment on its head. Right now, AST SpaceMobile (NASDAQ: ASTS) investors are staring down the barrel of one such lawsuit. With the November 13, 2026, deadline looming, it's time to sort the facts from the muck. Pins and Needles for ASTS...

Continue Reading
Lilly's Sofe-M Shakes Up Ovarian Cancer Treatment

Updated Category News Views 303

Ovarian Cancer Treatment Sees a New Challenger Alright, folks, Eli Lilly (NYSE:LLY) is stepping up with their latest findings in ovarian cancer treatment, and it's got plenty of people in a buzz. They've dropped new data for their investigational drug, Sofetabart mipitecan, or 'Sofe-M' for short, which targets this unrelenting disease with a punch that’s hard to ignore....

Continue Reading
CSTS Unveils PremierX in NYC: A Bold Entertainment Move

Updated Category News Views 185

Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...

Continue Reading
Amgen's IMDELLTRA® Shows Promise in SCLC Battle

Updated Category News Views 292

Breakthrough Results in SCLC Treatment For years, small cell lung cancer (SCLC) has been the unruly beast in the oncology world, defying treatment advances and keeping survival rates stubbornly low. This nasty foe might just have met its match, folks. Amgen (NASDAQ:AMGN) announced results from their Phase 3 DeLLphi-305 trial that show their drug IMDELLTRA®, when teamed...

Continue Reading
Likang's Bold Move: Cancer Immunotherapy at AD Summit

Updated Category News Views 96

Cancer Care Takes Center Stage Kicking off with a bang in Abu Dhabi, Likang Life Sciences has made a splash in the world of personalized cancer immunotherapy. The Abu Dhabi Future Health Summit 2026 served as the backdrop for this bold move, lighting up discussions with their AI-enabled innovations. Likang's showing at the Summit wasn't just another walk in the park—it...

Continue Reading
Taiwan Fuses Ancient TCM with Modern Bio Tech in 2026

Updated Category News Views 146

The Dynamic Fusion of Heritage and Innovation When you think about it, mixing centuries-old herbal wisdom with today's cutting-edge biotech might sound like a plot twist, but that's exactly what's cooking in Taiwan. Over at SupplySide Global 2026 in Las Vegas, Taiwan's got something more than just traditional medicine to flaunt; it's showcasing an impressive fusion of...

Continue Reading
Bio-Thera's New Data: A Game Changer for NSCLC?

Updated Category News Views 239

A Fresh Look at Lung Cancer Solutions There's fresh meat on the oncology block, with Bio-Thera Solutions swinging for the fences at ESMO 2026, spotlighting promising Phase 2 clinical data for their combo treatment in first-line non-small cell lung cancer (NSCLC). If you're tuned into the biopharmaceutical sector or just keeping tabs on global health romps, this news sets...

Continue Reading

Top 5 Most Recently Viewed Articles

Heights Wellness Retreat: A Bold Step Towards Holistic Wellness

Updated Category News Views 227

Heights Wellness Retreat: A New Era of Wellness In a landmark announcement during their annual summit, Massage Heights unveiled a significant transformation that redefines their brand identity. The brand, known for its commitment to wellness over the past two decades, will now operate under the name Heights Wellness Retreat. This evolution is more than just a new name; it...

Continue Reading
GeneDx Strengthens Leadership with New COO Appointment

Updated Category News Views 168

GeneDx Welcomes Bryan Dechairo as Chief Operating Officer GeneDx (NASDAQ: WGS) has made headlines with the appointment of Bryan Dechairo as its new Chief Operating Officer. This strategic decision aims to enhance operations and drive the company’s next phase of growth. Enhancing Operations for Future Success As COO, Dechairo will oversee critical areas including Product...

Continue Reading
FreightCar America to Share Q1 2025 Financial Results Soon

Updated Category News Views 130

FreightCar America Prepares for Q1 2025 Earnings Announcement FreightCar America, Inc. (NASDAQ: RAIL), a prominent player in the manufacturing of railroad freight cars, is gearing up to release its financial results for the first quarter of 2025. This important announcement is scheduled for after the market closes on a Monday, allowing investors and stakeholders to digest...

Continue Reading
Empowering Veterans: United Food Group's New Initiative

Updated Category News Views 129

United Food Group Unveils New Employment Initiative United Food Group, a noted developer and manufacturer of coffee equipment, powdered condiments, and beverages, has announced an innovative employment initiative designed to support wounded veterans and first responders. This program not only aims to empower these individuals but also provides them with specialized...

Continue Reading
US Futures Gain on Peace Talk Hopes Amid Market Developments

Updated Category News Views 206

U.S. Stock Futures Trend Upward U.S. stock futures saw an increase following the extended weekend, coming off a mixed trading day last Friday. The day off for Presidents Day allowed investors to reassess their positions. As a result, all four major indices posted gains in premarket trading. Investor Focus on Macro Conditions In today's trading, investors will closely...

Continue Reading